Nicolas Béranger

TTP: From empiricism for an enigmatic disease to targeted molecular therapies

J. Voorberg, P. Coppo, Nuno A G Graça, 2022, British journal of haematology.

von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate‐to‐severe COVID‐19 patients

B. Mégarbane, D. Sène, P. Bonnin, 2020, British journal of haematology.

Diagnosis and follow‐up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay

P. Coppo, A. Veyradier, A. Stépanian, 2020, Research and practice in thrombosis and haemostasis.

Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura.

P. Coppo, A. Veyradier, A. Stépanian, 2019, Thrombosis research.

Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID‐19 patients

É. Azoulay, M. Darmon, K. Vanhoorelbeke, 2021, Journal of Thrombosis and Haemostasis.

Multifactorial hypercoagulable state associated with a thrombotic phenotype in phosphomannomutase-2 congenital disorder of glycosylation (PMM2-CDG): Case report and brief review of the literature.

L. Drouet, V. Siguret, P. Charles, 2019, Thrombosis research.